Pedersen 2015 Scand J Med Sci Sports

From Bioblast
Revision as of 22:07, 1 June 2022 by Gnaiger Erich (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision β†’ (diff)
Publications in the MiPMap
Pedersen BK, Saltin B (2015) Exercise as medicine - evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand J Med Sci Sports 25:1-72.

Β» PMID: 26606383 Open Access

Pedersen BK, Saltin B (2015) Scand J Med Sci Sports

Abstract: This review provides the reader with the up-to-date evidence-based basis for prescribing exercise as medicine in the treatment of 26 different diseases: psychiatric diseases (depression, anxiety, stress, schizophrenia); neurological diseases (dementia, Parkinson's disease, multiple sclerosis); metabolic diseases (obesity, hyperlipidemia, metabolic syndrome, polycystic ovarian syndrome, type 2 diabetes, type 1 diabetes); cardiovascular diseases (hypertension, coronary heart disease, heart failure, cerebral apoplexy, and claudication intermittent); pulmonary diseases (chronic obstructive pulmonary disease, asthma, cystic fibrosis); musculo-skeletal disorders (osteoarthritis, osteoporosis, back pain, rheumatoid arthritis); and cancer. The effect of exercise therapy on disease pathogenesis and symptoms are given and the possible mechanisms of action are discussed. We have interpreted the scientific literature and for each disease, we provide the reader with our best advice regarding the optimal type and dose for prescription of exercise.

β€’ Bioblast editor: Gnaiger E

Labels: MiParea: Exercise physiology;nutrition;life style  Pathology: Cancer, Cardiovascular, Diabetes, Neurodegenerative, Obesity, Parkinson's, Other 

Organism: Human 

MitoFit news, Comorbidity 


MitoFit news 2015#20

  • 2015-12-22: Quote from Pedersen and Saltin (2015): ’.. it is now time that the health systems create the necessary infrastructure to ensure that supervised exercise can be prescribed as medicine.’ Β» MitoFit news
Cookies help us deliver our services. By using our services, you agree to our use of cookies.